EBS Equity Snapshot

BIOV Weekly Equity Report

BioVersys AG

Interactive chart JSON snapshot
Latest Close 26.20 CHF 12 Jun 2026
1W Return -4.0% latest completed week
4W Return -2.6% short-term follow-through
12W Return -7.4% quarterly tape
Trend Breadth 17.3% 9 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

BioVersys AG researches and develops antimicrobial drugs for bacterial infections. It develops BV100 that is in Phase 3 clinical trial for carbapenem-resistant Acinetobacter baumannii lung and bloodstream infections. The company is also developing Alpibectir, which is in Phase 2 clinical trial for the treatment of pulmonary and meningeal tuberculosis; BV200 to treat patients with Gram-positive S. aureus; and BV500 for non-tuberculous mycobacteria infections. It has a research and license option agreement with Shionogi & Co., Ltd. to develop ansamycin leads from the BV500 program into clinical candidates. The company was founded in 2008 and is …

Snapshot

What the weekly tape is saying

BIOV closed the latest completed week at 26.20 CHF. The 4-week return is -2.6% and the 12-week return is -7.4%. Trend Signal is active, Market Dynamics is -0.04. Setup signature: Risk-first tape with a 32/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 1.8%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 41 Persistence of active Trend Signal over the last year and current streak.
Momentum 37 Blend of 4-week and 12-week follow-through.
Dynamics 41 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 12 Relative leadership and short-term RS change.
Volume 38 Participation compared with the 13-week volume baseline.
Risk Control 21 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
25.74 CHF
Vs Trend Line
1.8%
Fair Value
29.54 CHF
Vs Fair Value
-11.3%
52W High
36.00 CHF
52W Low
21.20 CHF
Drawdown
-27.2%
Range Position
33.8%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -4.0%
4W -2.6%
12W -7.4%
26W 9.2%
52W -25.4%

Trend read

Active Streak
9 weeks
52W Active Weeks
9
52W Active Breadth
17.3%
Sector Scope
CH Healthcare
Sector Rank
35 of 41
Sector Percentile
15.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.04
4W MD Change
-107.2%
Relative Strength
-11.78
4W RS Change
-32.1%
Expectation
Undecided
Probability
46.88%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
8.9K
13W Average
9.7K
52W Average
15.8K
Vs 13W
0.9x
Vs 52W
0.6x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.8%
52W Volatility
6.7%
Upside Weeks
23
Downside Weeks
25
Downside Breadth
48.1%
Avg Gain / Loss
5.2% / -5.5%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
EBS
Country
CH
Sector
Healthcare
Industry
Biotechnology
Currency
CHF
Market Cap
157.9M

Opportunity signals

  • Trend Signal is active with a 9-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.

Risk signals

  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.
  • Latest weekly return ranks in the weaker part of its sector group.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 26.20 CHF -4.0% 25.74 CHF 29.54 CHF -0.04 -11.78 8.9K On
5 Jun 2026 27.30 CHF 1.1% 25.69 CHF 29.58 CHF 0.11 -6.70 3.5K On
29 May 2026 27.00 CHF 0.0% 25.66 CHF 29.62 CHF 0.33 -9.38 1.8K On
22 May 2026 27.00 CHF 0.4% 25.56 CHF 29.66 CHF 0.51 -9.85 11.6K On
15 May 2026 26.90 CHF -2.5% 25.45 CHF 29.70 CHF 0.62 -8.92 2.8K On
8 May 2026 27.60 CHF -2.8% 25.37 CHF 29.74 CHF 0.84 -6.33 6.8K On
1 May 2026 28.40 CHF -0.7% 25.37 CHF 29.77 CHF 0.86 -4.47 5.2K On
24 Apr 2026 28.60 CHF -1.7% 25.36 CHF 29.79 CHF 1.02 -4.58 5.4K On
17 Apr 2026 29.10 CHF 9.8% 25.36 CHF 29.81 CHF 1.14 -5.32 7.4K On
10 Apr 2026 26.50 CHF -10.5% 25.49 CHF 29.82 CHF 1.21 -12.75 13.5K Off
3 Apr 2026 29.60 CHF -1.3% 25.64 CHF 29.88 CHF 1.39 -1.94 20.5K Off
27 Mar 2026 30.00 CHF 6.0% 25.70 CHF 29.88 CHF 1.29 2.03 22.4K Off
20 Mar 2026 28.30 CHF 4.4% 25.68 CHF 29.88 CHF 1.06 -2.14 16.3K Off
13 Mar 2026 27.10 CHF 5.9% 25.56 CHF 29.91 CHF 0.79 -10.37 32.1K Off